Fernie A. Van Beest-Penning
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Real-world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network.
Journal: Diabetes, obesity & metabolism
Published: July 25, 2025
Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases.
Journal: Current medical research and opinion
Published: May 17, 2025
Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 22, 2024
Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
Journal: Respiratory research
Published: July 28, 2023
Incidence of Lyme Borreliosis in the Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019.
Journal: Vector borne and zoonotic diseases (Larchmont, N.Y.)
Published: April 18, 2023
Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case-Control Study from The Netherlands, Italy and Germany.
Journal: Drugs - real world outcomes
Published: May 29, 2022
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
Journal: Drugs - real world outcomes
Published: November 24, 2021
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands.
Journal: Journal of medical economics
Published: October 28, 2021
Reduction in use of cyproterone/ethinylestradiol (Diane-35 and generics) after risk minimization measures in the Netherlands, UK and Italy.
Journal: Contraception
Published: April 23, 2020
Existing Data Sources for Clinical Epidemiology: The PHARMO Database Network.
Journal: Clinical epidemiology
Published: January 29, 2020
Evaluating the Effectiveness of an Additional Risk Minimization Measure to Reduce the Risk of Prescribing Mirabegron to Patients with Severe Uncontrolled Hypertension in Four European Countries.
Journal: Clinical epidemiology
Published: December 19, 2019
Last Updated: 09/26/2026